FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ingo Schmidt-Wolf

Research Profile

Anatomy

Physiology

Chemicals & Drugs

Procedures

Disorders

Living Beings

Mouse

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Stefan Gröschel; Marije Havermans; Jürgen Krauter; Michael W M Kühn; Bob Löwenberg; Michael Lübbert; Gert J Ossenkoppele; Thomas Pabst; Veronika Rockova; Brigitte Schlegelberger; Richard F Schlenk; Ingo G H Schmidt-Wolf; Gerrit J Schuurhuis; Veronica Teleanu; Peter J M Valk; Peter Vandenberghe; Edo Vellenga; Leo F Verdonck; Gregor Verhoef; Hartmut Döhner; Konstanze Döhner; Karina Eiwen; Jan Engelmann; Claudia Erpelinck; Arnold Ganser; Ulrich Germing; Mario Bargetzi; Berna Beverloo; Ruud Delwel
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Hui Zhi Low; Ingo G H Schmidt-Wolf; Dorothee Hilbrans; Harald Illges
Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression.
Pieter Sonneveld; Marian Stevens-Kroef; Bronno van der Holt; Helgi van der Velde; Marinus van Marwijk Kooy; Edo Vellenga; Katja C Weisel; Pierre W Wijermans; Shulamiet Wittebol; Sonja Zweegman; Dirk Hose; Anna Jauch; Marie-Jose Kersten; Walter Lindemann; Henk M Lokhorst; Michael Pfreundschuh; Reinier Raymakers; Hans Salwender; M Ronald Schaafsma; Christof Scheid; Ingo G H Schmidt-Wolf; Uta Bertsch; Igor W Blau; Gerard M J Bos; Annemiek Broyl; Ulrich Duehrsen; Laila El Jarari; Hartmut M Goldschmidt
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ingo Schmidt-Wolf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stefan Gröschel; Marije Havermans; Jürgen Krauter; Michael W M Kühn; Bob Löwenberg; Michael Lübbert; Gert J Ossenkoppele; Thomas Pabst; Veronika Rockova; Brigitte Schlegelberger; Richard F Schlenk; Ingo G H Schmidt-Wolf; Gerrit J Schuurhuis; Veronica Teleanu; Peter J M Valk; Peter Vandenberghe; Edo Vellenga; Leo F Verdonck; Gregor Verhoef; Hartmut Döhner; Konstanze Döhner; Karina Eiwen; Jan Engelmann; Claudia Erpelinck; Arnold Ganser; Ulrich Germing; Mario Bargetzi; Berna Beverloo; Ruud Delwel
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(1):95-103.
2012: Hui Zhi Low; Ingo G H Schmidt-Wolf; Dorothee Hilbrans; Harald Illges
Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression.
International journal of hematology 2012;96(3):350-6.
2012: Pieter Sonneveld; Marian Stevens-Kroef; Bronno van der Holt; Helgi van der Velde; Marinus van Marwijk Kooy; Edo Vellenga; Katja C Weisel; Pierre W Wijermans; Shulamiet Wittebol; Sonja Zweegman; Dirk Hose; Anna Jauch; Marie-Jose Kersten; Walter Lindemann; Henk M Lokhorst; Michael Pfreundschuh; Reinier Raymakers; Hans Salwender; M Ronald Schaafsma; Christof Scheid; Ingo G H Schmidt-Wolf; Uta Bertsch; Igor W Blau; Gerard M J Bos; Annemiek Broyl; Ulrich Duehrsen; Laila El Jarari; Hartmut M Goldschmidt
Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(24):2946-55.
2012: Hannah Koppitz; Hans Konrad Müller-Hermelink; Jürgen K Rockstroh; Heinrich Schüller; Dirk Skowasch; Jens Standop; Ingo G H Schmidt-Wolf
State-of-the-art classification and multimodality treatment of malignant thymoma.
Cancer treatment reviews 2012;38(5):540-8.
2012: Clara E Jäkel; Young Kim; Karoline Meschenmoser; Hans Weiher; Ingo G H Schmidt-Wolf
Efficacy of a proapoptotic peptide towards cancer cells.
In vivo (Athens, Greece) 2012;26(3):419-26.
2012: Young Kim; Desheng Lu; Dennis Carson; Tomoyuki Endo; Sanna-Marie Gast; Ingo G H Schmidt-Wolf
In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma.
Leukemia research 2012;36(5):598-600.
2012: Volker Kunzmann; Ingo G H Schmidt-Wolf; Manfred Smetak; Karin Weigang-Koehler; Jürgen Becker; Josef Birkmann; Hermann Einsele; Mariele Goebeler; Brigitte Kimmel; Martin Wilhelm
Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012;35(2):205-13.
2012: Kai Neben; Norma Peter; Michael Pfreundschuh; Marc S Raab; Hans Salwender; Christof Scheid; Ingo G H Schmidt-Wolf; Pieter Sonneveld; Christian Teschendorf; Helgi van de Velde; Bronno van der Holt; Katja Weisel; Mathias Haenel; Thomas Hielscher; Anthony D Ho; Dirk Hose; Anna Jauch; Walter Lindemann; Henk M Lokhorst; Hans Martin; Uta Bertsch; Igor W Blau; Hans G Derigs; Ulrich Dührsen; Hartmut Goldschmidt
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.
Blood 2012;119(4):940-8.
2012: Clara E Jäkel; Stefan C Müller; Sebastian Rogenhofer; P Brossart; Stefan Hauser; Ingo G H Schmidt-Wolf
Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma.
Clinical & developmental immunology 2012;2012():473245.
2012: Claudia Schlimper; Hinrich Abken; Andreas A Hombach; Ingo G H Schmidt-Wolf
Improved activation toward primary colorectal cancer cells by antigen-specific targeting autologous cytokine-induced killer cells.
Clinical & developmental immunology 2012;2012():238924.
2012: Moritz Stuplich; Sharmilan Thanendrarajan; Martin Glas; Young Kim; Karin Mayer; Niklas Schäfer; Ingo G H Schmidt-Wolf; Matthias Simon; Ulrich Herrlinger
Richter syndrome and brain involvement: low-grade lymphoma relapsing as cerebral high-grade lymphoma.
Acta haematologica 2012;127(2):93-5.
2011: Young Kim; Desheng Lu; Matthias Schmidt; Dennis Carson; Tomoyuki Endo; Ingo G H Schmidt-Wolf
Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.
In vivo (Athens, Greece) 2011;25(6):887-93.
2011: Sharmilan Thanendrarajan; Hinrich Abken; Michael Nowak; Ingo G H Schmidt-Wolf
Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one?
Leukemia research 2011;35(9):1136-42.
2011: Diahnn Futalan; Chien-Tze Huang; Marie Larsson; Ingo G H Schmidt-Wolf; Davorka Messmer
Effect of oxygen levels on the physiology of dendritic cells: implications for adoptive cell therapy.
Molecular medicine (Cambridge, Mass.) 2011;17(9-10):910-6.
2011: Young Kim; Simon Krämer; Desheng Lu; Petra Alpmann; Sabine Blaum-Feder; Dennis Carson; Tomoyuki Endo; Ingo G H Schmidt-Wolf
In vivo efficacy of griseofulvin against multiple myeloma.
Leukemia research 2011;35(8):1070-3.
2011: Matthias Schmidt; Young Kim; Sanna-Marie Gast; Tomoyuki Endo; Desheng Lu; Dennis Carson; Ingo G H Schmidt-Wolf
Increased in vivo efficacy of lenalidomide and thalidomide by addition of ethacrynic acid.
In vivo (Athens, Greece) 2011;25(3):325-33.
2011: Verena I Gaidzik; Lars Bullinger; Richard F Schlenk; Andreas S Zimmermann; Jürgen Röck; Peter Paschka; Andrea Corbacioglu; Jürgen Krauter; Brigitte Schlegelberger; Arnold Ganser; Daniela Späth; Andrea Kündgen; Ingo G H Schmidt-Wolf; K Götze; David Nachbaur; Michael Pfreundschuh; Heinz A Horst; Hartmut Döhner; Konstanze Döhner
RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(10):1364-72.
2011: Young Kim; Guido Reifenberger; Desheng Lu; Tomoyuki Endo; Dennis A Carson; Sanna-Marie Gast; Karoline Meschenmoser; Michael Nowak; Ingo G H Schmidt-Wolf
Influencing the Wnt signaling pathway in multiple myeloma.
Anticancer research 2011;31(2):725-30.
2011: Katharina Schwamborn; Axel Glasmacher; Marcus Gorschlüter; Ingo G H Schmidt-Wolf
Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma.
German medical science : GMS e-journal 2011;9():Doc26.
2011: Björn Schöttker; Ingo G H Schmidt-Wolf
Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells.
German medical science : GMS e-journal 2011;9():Doc18.
2011: Katrin Patrij; Hendrik Pels; Marcel Reiser; Gabriele Schackert; Uwe Schlegel; Ingo G H Schmidt-Wolf; Marlies Vogt-Schaden; Luise Wätzel; Tracy T Batchelor; Gerlinde Egerer; Andreas Engert; Ulrich Herrlinger; Annika Kowoll; Monika Lamprecht; Michael Linnebank
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.
German medical science : GMS e-journal 2011;9():Doc11.
2011: Young Kim; Petra Alpmann; Sabine Blaum-Feder; Simon Krämer; Tomoyuki Endo; Desheng Lu; Dennis Carson; Ingo G H Schmidt-Wolf
Increased in vivo efficacy of lenalidomide by addition of piroctone olamine.
In vivo (Athens, Greece) 2011;25(1):99-103.
2010: Yang Li; Ingo G H Schmidt-Wolf; Yan-Feng Wu; Shao-Liang Huang; Jing Wei; Jianpei Fang; Ke Huang; Dun-hua Zhou
Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cells.
Anticancer research 2010;30(9):3493-9.
2010: Markus Kraemer; Stefan Hauser; Ingo G H Schmidt-Wolf
Long-term survival of patients with metastatic renal cell carcinoma treated with pulsed dendritic cells.
Anticancer research 2010;30(6):2081-6.
2010: Marie von Lilienfeld-Toal; Susanne Frank; Christiane Leyendecker; Sylvia Feyler; Sarah Jarmin; Ruth Morgan; Axel Glasmacher; Angela Märten; Ingo G H Schmidt-Wolf; Peter Brossart; Gordon Cook
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
Cancer immunology, immunotherapy : CII 2010;59(6):829-39.
2010: Anjali Advani; Bertrand Coiffier; Myron S Czuczman; Martin Dreyling; James Foran; Eva Gine; Christian Gisselbrecht; Nicolas Ketterer; Sunita Nasta; Ama Rohatiner; Ingo G H Schmidt-Wolf; Martin Schuler; Jorge Sierra; Mitchell R Smith; Gregor Verhoef; Jane N Winter; Joseph Boni; Erik Vandendries; Mark Shapiro; Luis Fayad
Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(12):2085-93.
2010: Annika Juergens; Hendrik Pels; Sabine Rogowski; Klaus Fliessbach; Axel Glasmacher; Andreas Engert; Marcel Reiser; Volker Diehl; Marlies Vogt-Schaden; Gerlinde Egerer; Gabriele Schackert; Heinz Reichmann; Frank Kroschinsky; Udo Bode; Ulrich Herrlinger; Michael Linnebank; Martina Deckert; Rolf Fimmers; Ingo G H Schmidt-Wolf; Uwe Schlegel
Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.
Annals of neurology 2010;67(2):182-9.
2010: Young Kim; John Strehl; Elisabeth Sievers; Marcus Gorschlüter; Peter Brossart; Ingo G H Schmidt-Wolf
CD40L-transfected myeloma cells transfer prolonged immunity in vivo.
In vivo (Athens, Greece) 2010;24(1):45-8.
2009: Carsten Ziske; Patricia E Etzrodt; Alex-S Eliu; Marcus Gorschlüter; John Strehl; Dimitri Flieger; Davorka Messmer; Volker Schmitz; Maria A Gonzalez-Carmona; Elisabeth Sievers; Peter Brossart; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids.
Pancreas 2009;38(7):758-65.
2009: Andrea Linke; Peter Brossart; Ingo G H Schmidt-Wolf; Maria A Gonzalez-Carmona; Carsten Ziske; Davorka Messmer; Volker Schmitz; Tilman Sauerbruch
Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model.
Pancreas 2009;38(5):602-4.
2009: Matthias Schmidt; Elisabeth Sievers; Tomoyuki Endo; Desheng Lu; Dennis Carson; Ingo G H Schmidt-Wolf
Targeting Wnt pathway in lymphoma and myeloma cells.
British journal of haematology 2009;144(5):796-8.
2009: Hendrik Pels; Annika Juergens; Axel Glasmacher; Holger Schulz; Andreas Engert; Michael Linnebank; Gabriele Schackert; Heinz Reichmann; Frank Kroschinsky; Marlies Vogt-Schaden; Gerlinde Egerer; Udo Bode; Carlo Schaller; Monika Lamprecht; Peter Hau; Martina Deckert; Rolf Fimmers; Christopher Bangard; Ingo G H Schmidt-Wolf; Uwe Schlegel
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study.
Journal of neuro-oncology 2009;91(3):299-305.
2009: Michael Linnebank; Susanna Moskau; Annika Jürgens; Matthias Simon; Alexander Semmler; Katjana Orlopp; Axel Glasmacher; Christopher Bangard; Marlies Vogt-Schaden; Horst Urbach; Ingo G H Schmidt-Wolf; Hendrik Pels; Uwe Schlegel
Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.
Neuro-oncology 2009;11(1):2-8.
2009: Desheng Lu; Jerry X Liu; Tomoyuki Endo; Haowen Zhou; Shiyin Yao; Karl Willert; Ingo G H Schmidt-Wolf; Thomas J Kipps; Dennis A Carson
Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
PloS one 2009;4(12):e8294.
2009: Anja Kraemer; Stefan Hauser; Young Kim; Marcus Gorschlüter; Stefan C Müller; Peter Brossart; Ingo G H Schmidt-Wolf
Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide.
German medical science : GMS e-journal 2009;7():Doc04.
2008: Srinivas Nagaraj; Juergen Neumann; Bettina Winzen; Susanne Frank; Carsten Ziske; Elisabeth Sievers; Norbert Koch; Ingo G H Schmidt-Wolf
Pancreas carcinoma antigen fused to invariant chain elicits T-cell response and tumor growth inhibition.
Pancreas 2008;37(3):321-7.
2008: Marcus Gorschlüter; Volker Schmitz; Ulrich Mey; Corinna Hahn-Ast; Ingo G H Schmidt-Wolf; Tilman Sauerbruch
Endoscopy in patients with acute leukaemia after intensive chemotherapy.
Leukemia research 2008;32(10):1510-7.
2008: Olav Gressner; Henning Popp; Ulrich Mey; Nicolaus Friedrichs; John Strehl; Tilman Sauerbruch; Ingo G H Schmidt-Wolf; Marcus Gorschlüter
Long-term survival of a patient with small cell lung cancer after nine lines of chemotherapy and radiation.
Onkologie 2008;31(8-9):469-72.
2008: Maria A Gonzalez-Carmona; Veronika Lukacs-Kornek; Anne Timmerman; Sara Shabani; Miroslaw Kornek; Annabelle Vogt; Yildiz Yildiz; Elisabeth Sievers; Ingo G H Schmidt-Wolf; Wolfgang H Caselmann; Tilman Sauerbruch; Volker Schmitz
CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Hepatology (Baltimore, Md.) 2008;48(1):157-68.
2008: Young Kim; John Strehl; Marcus Gorschlüter; Carsten Ziske; Ingo G H Schmidt-Wolf
Prevention of lethal tumor growth and generation of long-lasting immunity in vivo using CD137L and interleukin-12 gene transfer.
In vivo (Athens, Greece) 2008;22(3):337-43.
2008: Carsten Ziske; Klaus Tiemann; Tanja Schmidt; Srinivas Nagaraj; Angela Märten; Volker Schmitz; Ricarda Clarenbach; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Real-time high-resolution compound imaging allows percutaneous initiation and surveillance in an orthotopic murine pancreatic cancer model.
Pancreas 2008;36(2):146-52.
2008: Ines Gütgemann; Kathryn Stevens; David Loftus; Ingo G H Schmidt-Wolf; Tracy I George
VEGF and osteosclerosis in POEMS syndrome.
Annals of hematology 2008;87(3):243-5.
2008: Akihiko Shimomura; Marie von Lilienfeld-Toal; Zeynep Balta; Elisabeth Schroers; Ingo G H Schmidt-Wolf; Reinhard Büttner; Alexander von Rücker; Ines Gütgemann
Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.
Annals of hematology 2008;87(3):255-6.
2007: Anja Lorch; Christian Kollmannsberger; Jörg Thomas Hartmann; Bernd Metzner; Ingo G H Schmidt-Wolf; Wolfgang E Berdel; Florian Weissinger; Jan Schleicher; Gerlinde Egerer; Antje Haas; Rebekka Schirren; Jörg Beyer; Carsten Bokemeyer; Oliver Rick
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2778-84.
2007: Jan-Peter Hedde; Thomas Neuhaus; Heinrich Schüller; Ute Metzler; Ingo G H Schmidt-Wolf; Rolf Kleinschmidt; Christoph Losem; Oliver Lange; Christian Grohe; Sebastian Stier; Yon-Dschun Ko
A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors.
International journal of radiation oncology, biology, physics 2007;68(3):839-44.
2007: Ulrich Mey; Anna Maier; Ingo G H Schmidt-Wolf; Carsten Ziske; Helmut Forstbauer; Gamal-Andre Banat; Michael Reber; John Strehl; Marcus Gorschlueter
Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(7):877-84.
2007: Iris Breitkreutz; Henk M Lokhorst; Marc S Raab; B van der Holt; Friedrich W Cremer; Doris Herrmann; Axel Glasmacher; Ingo G H Schmidt-Wolf; I W Blau; H Martin; Hans Salwender; A Haenel; Pieter Sonneveld; Hartmut Goldschmidt
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
Leukemia 2007;21(6):1294-9.
2007: Gary R Hudes; Michael A Carducci; Piotr Tomczak; Janice Dutcher; Robert Figlin; Anil Kapoor; Elzbieta Staroslawska; Jeffrey A Sosman; David McDermott; István Bodrogi; Zoran Kovacevic; Vladimir Lesovoy; Ingo G H Schmidt-Wolf; Olga Barbarash; Erhan Gokmen; Timothy O'Toole; Stephanie Lustgarten; Laurence Moore; Robert J Motzer
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
The New England journal of medicine 2007;356(22):2271-81.
2007: Dimitri Flieger; Michael Varvenne; Rolf Kleinschmidt; Ingo G H Schmidt-Wolf
Influence of immunomodulatory drugs on the cytotoxicity induced by monoclonal antibody 17-1A and interleukin-2.
Cellular immunology 2007;246(1):26-33.
2007: Marcus Gorschlüter; Axel Glasmacher; Susann Sarazin; Frank Hackbarth; Eckfried Hoebert; Katjana Orlopp; Ingo G H Schmidt-Wolf; Ulrich Mey
CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: a retrospective study.
Leukemia & lymphoma 2007;48(3):506-12.
2007: Cornelius Courts; Manuel Montesinos-Rongen; Jose I Martin-Subero; Anna Brunn; Dörte Siemer; Reina Zühlke-Jenisch; Hendrik Pels; Annika Jürgens; Uwe Schlegel; Ingo G H Schmidt-Wolf; Carlo Schaller; Guido Reifenberger; Michael S Sabel; Ute Warnecke-Eberz; Otmar D Wiestler; Ralf Küppers; Reiner Siebert; Martina Deckert
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.
Journal of neuropathology and experimental neurology 2007;66(3):230-7.
2007: Stefan Gütgemann; Susanne Frank; John Strehl; Ingo G H Schmidt-Wolf
Cytokine-induced killer cells are type II natural killer T cells.
German medical science : GMS e-journal 2007;5():Doc07.
2007: Ulrich Mey; Vandana Jha; John Strehl; Marcus Gorschlueter; Christian Rabe; Eckfried Hoebert; Henning Popp; Ingo G H Schmidt-Wolf
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma.
German medical science : GMS e-journal 2007;5():Doc02.
2007: Elisabeth Sievers; Patrick Dreimuller; Axel Haferkamp; Ingo G H Schmidt-Wolf; Markus W Buchler; Jan Schmidt; Angela Marten
Characterization of primary renal carcinoma cultures.
Urologia internationalis 2007;79(3):235-43.
2007: Frank Schakowski; Marcus Gorschlüter; Peter Buttgereit; Angela Märten; Marie V Lilienfeld-Toal; Claas Junghans; Matthias Schroff; Sven A König-Merediz; Carsten Ziske; John Strehl; Tilman Sauerbruch; Burghardt Wittig; Ingo G H Schmidt-Wolf
Minimal size MIDGE vectors improve transgene expression in vivo.
In vivo (Athens, Greece) 2007;21(1):17-23.
2006: Ulrich Mey; Attilio Olivieri; Katjana Orlopp; Christian Rabe; John Strehl; Marcus Gorschlueter; Manfred Hensel; Dimitri Flieger; Axel Glasmacher; Ingo G H Schmidt-Wolf
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis.
Leukemia & lymphoma 2006;47(12):2558-66.
2006: Davorka Messmer; Ikusuke Hatsukari; Naoko Hitosugi; Ingo G H Schmidt-Wolf; Pravin Singhal
Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation.
Molecular medicine (Cambridge, Mass.) 2006;12(11-12):284-90.
2006: Michael Erhardt; Ingo G H Schmidt-Wolf; Elisabeth Sievers; Susanne Frank; John Strehl; Marie von Lilienfeld-Toal; Marcus Gorschlüter
Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells.
Archivum immunologiae et therapiae experimentalis 2006;54(6):403-9.
2006: Gloria Telusma; Sandip Datta; Ivan Mihajlov; Wenxue Ma; Jianhua Li; Huan Yang; Walter Newman; Bradley T Messmer; Boris Minev; Ingo G H Schmidt-Wolf; Kevin Tracey; Nicholas Chiorazzi; Davorka Messmer
Dendritic cell activating peptides induce distinct cytokine profiles.
International immunology 2006;18(11):1563-73.
2006: Ulrich Mey; Katjana Orlopp; Dimitri Flieger; John Strehl; Anthony Ho; Manfred Hensel; Cordula Bopp; Marcus Gorschlüter; Martin Wilhelm; Josef Birkmann; Ulrich Kaiser; Andreas Neubauer; Axel Florschütz; Christian Rabe; Corinna Hahn; Axel Glasmacher; Ingo G H Schmidt-Wolf
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Cancer investigation 2006;24(6):593-600.
2006: Srinivas Nagaraj; Carsten Ziske; John Strehl; D Messmer; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo.
International immunology 2006;18(8):1279-83.
2006: Andreas Hombach; Claudia Schlimper; E Sievers; S Frank; H H Schild; T Sauerbruch; Ingo G H Schmidt-Wolf; Hinrich Abken
A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
Gut 2006;55(8):1156-64.
2006: Marie von Lilienfeld-Toal; Jacob Nattermann; Georg Feldmann; Elisabeth Sievers; S Frank; John Strehl; Ingo G H Schmidt-Wolf
Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
Clinical and experimental immunology 2006;144(3):528-33.
2006: Ingo G H Schmidt-Wolf; Axel Glasmacher; Corinna Hahn-Ast; A Jüttner; T Schnurr; Friedrich W Cremer; T Moehler; Hartmut Goldschmidt; B Busert; R Schubert; Gesa Schwanitz
Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
Cancer genetics and cytogenetics 2006;167(1):20-5.
2006: Maria A González-Carmona; Angela Märten; Per Hoffmann; Carlo Schneider; Elisabeth Sievers; Ingo G H Schmidt-Wolf; Tilman Sauerbruch; Wolfgang H Caselmann
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
Liver international : official journal of the International Association for the Study of the Liver 2006;26(3):369-79.
2006: Rudolf Weiss; Paris Mitrou; Keikawus Arastéh; Dirk Schuermann; Marcus Hentrich; Ulrich Duehrsen; Hinrich Sudeck; Ingo G H Schmidt-Wolf; Ioannis Anagnostopoulos; Dieter Huhn
Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
Cancer 2006;106(7):1560-8.
2006: Christof Lamberti; S Lundin; Manuela Bogdanow; Marcus Gorschlüter; Ingo G H Schmidt-Wolf; Tilman Sauerbruch
[Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
Deutsche medizinische Wochenschrift (1946) 2006;131(10):485-90.
2006: Jan Schmidt; Eduard Ryschich; Elisabeth Sievers; Ingo G H Schmidt-Wolf; Markus W Büchler; Angela Märten
Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivo.
Cancer 2006;106(4):759-64.
2006: Björn-Christian Link; Carsten Ziske; Michael Schepke; Ingo G H Schmidt-Wolf; Tilman Sauerbruch
Total ascitic fluid leukocyte count for reliable exclusion of spontaneous bacterial peritonitis in patients with ascites.
European journal of gastroenterology & hepatology 2006;18(2):181-6.
2006: Holger Palmedo; Horst Urbach; Hans Bender; Uwe Schlegel; Ingo G H Schmidt-Wolf; Alexander Matthies; Michael Linnebank; Alexius Y Joe; Jan Bucerius; Hans-Jürgen Biersack; Hendrik Pels
FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.
European journal of nuclear medicine and molecular imaging 2006;33(2):164-8.
2006: Angela Märten; Elisabeth Sievers; Peter Albers; Stefan Müller; Christian Franchy; Alexander von Ruecker; Holger Strunk; Hans Heinz Schild; Alexandra Schmiedel; Thorsten Sommer; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
German medical science : GMS e-journal 2006;4():Doc02.
2006: Christof Lamberti; Elisabeth Mangold; Constanze Pagenstecher; Matthias Jungck; D Schwering; Magdolna Bollmann; J Vogel; D Kindermann; R Nikorowitsch; Nicolaus Friedrichs; B Schneider; Farzad Houshdaran; Ingo G H Schmidt-Wolf; Waltraut Friedl; Peter Propping; Tilman Sauerbruch; Reinhard Büttner; Micaela Mathiak
Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany.
Digestion 2006;74(1):58-67.
2006: Marcus Gorschlüter; Ulrich Mey; John Strehl; Volker Schmitz; Christian Rabe; Katharina Pauls; Carsten Ziske; Ingo G H Schmidt-Wolf; Axel Glasmacher
Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.
BMC infectious diseases 2006;6():35.
2005: Marcus Gorschlüter; Ulrich Mey; A Glasmacher; R Schwerdtfeger; Ingo G H Schmidt-Wolf
Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum.
Bone marrow transplantation 2005;36(12):1107.
2005: Axel Glasmacher; Marie von Lilienfeld-Toal; S Schulte; Corinna Hahn; Ingo G H Schmidt-Wolf; A Prentice
An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11 Suppl 5():17-23.
2005: Marcus Gorschlüter; Ulrich Mey; John Strehl; Carsten Ziske; Michael Schepke; Ingo G H Schmidt-Wolf; Tilman Sauerbruch; Axel Glasmacher
Neutropenic enterocolitis in adults: systematic analysis of evidence quality.
European journal of haematology 2005;75(1):1-13.
2005: Marie von Lilienfeld-Toal; Elisabeth Sievers; V Bodemüller; C Mihailescu; Angela Märten; Marcus Gorschlüter; Ingo G H Schmidt-Wolf
Coculture with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells.
Immunology letters 2005;99(1):103-8.
2005: Michael Erhardt; Marcus Gorschlüter; Jens Sager; Carsten Ziske; John Strehl; Marie V Lilienfeld-Toal; Ingo G H Schmidt-Wolf
Transfection of human monocyte-derived dendritic cells with CpG oligonucleotides.
Immunology and cell biology 2005;83(3):278-85.
2005: Klaus Fliessbach; Christoph Helmstaedter; Horst Urbach; A Althaus; Hendrik Pels; Michael Linnebank; A Juergens; Axel Glasmacher; Ingo G H Schmidt-Wolf; Thomas Klockgether; Uwe Schlegel
Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
Neurology 2005;64(7):1184-8.
2005: Michael Linnebank; Hendrik Pels; N Kleczar; Susan Farmand; Klaus Fliessbach; Horst Urbach; Katjana Orlopp; Thomas Klockgether; Ingo G H Schmidt-Wolf; Uwe Schlegel
MTX-induced white matter changes are associated with polymorphisms of methionine metabolism.
Neurology 2005;64(5):912-3.
2005: Hendrik Pels; Manuel Montesinos-Rongen; Carlo Schaller; Uwe Schlegel; Ingo G H Schmidt-Wolf; Otmar D Wiestler; Martina Deckert
VH gene analysis of primary CNS lymphomas.
Journal of the neurological sciences 2005;228(2):143-7.
2005: Christof Lamberti; K Di Blasi; D Archut; R Fimmers; Micaela Mathiak; Magdolna Bollmann; J Vogel; D Kindermann; Jörg Mezger; Ingo G H Schmidt-Wolf; Tilman Sauerbruch
Population-based registration of unselected colorectal cancer patients: five-year survival in the region of Bonn/Rhine-Sieg, Germany.
Zeitschrift für Gastroenterologie 2005;43(2):149-54.
2005: Oliver Bonn; Gabriele Schmidt-Wolf; Frank Risse; Axel Glasmacher; Rolf Kleinschmidt; Ingo G H Schmidt-Wolf
Vindesine and etoposide: A practical and well-tolerated therapy for elderly patients or patients in reduced clinical condition with extensive-stage small-cell lung cancer (SCLC).
Medical science monitor : international medical journal of experimental and clinical research 2005;11(2):PI19-21.
2005: Stefan Mehrle; Susanne Frank; Jan Schmidt; Ingo G H Schmidt-Wolf; Angela Märten
SAP and SLAM expression in anti-CD3 activated lymphocytes correlates with cytotoxic activity.
Immunology and cell biology 2005;83(1):33-9.
2005: Katjana Orlopp; Ingo G H Schmidt-Wolf; Horst Urbach; Uwe Schlegel
[Acute central nervous symptoms in oncologic patients].
Der Internist 2005;46(1):19-29.
2004: Eugen Leo; Lars Scheuer; Ingo G H Schmidt-Wolf; Mohammed Kerowgan; Christina Schmitt; Albrecht Leo; Tanja Baumbach; Alwin Kraemer; Ulrich Mey; Axel Benner; Reza Parwaresch; Anthony Ho
Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma.
European journal of haematology 2004;73(4):251-7.
2004: Carsten Ziske; Srinivas Nagaraj; Angela Märten; Marcus Gorschlüter; John Strehl; Tilman Sauerbruch; Nader G Abraham; Ingo G H Schmidt-Wolf
Retroviral IFN-alpha gene transfer combined with gemcitabine acts synergistically via cell cycle alteration in human pancreatic carcinoma cells implanted orthotopically in nude mice.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2004;24(8):490-6.
2004: Marie von Lilienfeld-Toal; M P Dietrich; Axel Glasmacher; L Lehmann; P Breig; Corinna Hahn; Ingo G H Schmidt-Wolf; Günter Marklein; S Schroeder; F Stuber
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(7):539-44.
2004: Michael Linnebank; S Schmidt; Heike Kölsch; Anja Linnebank; Reinhard Heun; Ingo G H Schmidt-Wolf; Axel Glasmacher; Klaus Fliessbach; Thomas Klockgether; Uwe Schlegel; Hendrik Pels
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma.
British journal of cancer 2004;90(10):1969-71.
2004: Srinivas Nagaraj; Carsten Ziske; Ingo G H Schmidt-Wolf
Dendritic cell, the immunotherapeutic cell for cancer.
The Indian journal of medical research 2004;119(4):133-8.
2004: Christian Rabe; Ulrich Mey; Michael Paashaus; Annemarie Musch; Selçuk Tasci; Axel Glasmacher; Ingo G H Schmidt-Wolf; Tilman Sauerbruch; Franz Ludwig Dumoulin
Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis.
Journal of critical care 2004;19(1):29-35.
2004: Axel Glasmacher; Hartmut Goldschmidt; Jörg Mezger; Torsten Haferlach; Ingo G H Schmidt-Wolf; Frank Gieseler
Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: final analysis of a phase II trial.
Haematologica 2004;89(3):371-3.
2004: C Schneider; T Schmidt; Carsten Ziske; Klaus Tiemann; K-M Lee; V Uhlinsky; P Behrens; Tilman Sauerbruch; Ingo G H Schmidt-Wolf; Peter F Mühlradt; Jan Schmidt; Angela Märten
Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model.
Gut 2004;53(3):355-61.
2004: Elisabeth Sievers; Peter Albers; Ingo G H Schmidt-Wolf; Angela Märten
Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma.
The Journal of urology 2004;171(1):114-9.
2003: Tanja Schmidt; Carsten Ziske; Angela Märten; Stefan Endres; Klaus Tiemann; Volker Schmitz; Marcus Gorschlüter; Christof Schneider; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
Cancer research 2003;63(24):8962-7.
2003: Axel Glasmacher; Archibald Prentice; Marcus Gorschlüter; Steffen Engelhart; Corinna Hahn; Benjamin Djulbegovic; Ingo G H Schmidt-Wolf
Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4615-26.
2003: Hendrik Pels; Ingo G H Schmidt-Wolf; Axel Glasmacher; Holger Schulz; Andreas Engert; Volker Diehl; Anton Zellner; Gabriele Schackert; Heinz Reichmann; Frank Kroschinsky; Marlies Vogt-Schaden; Gerlinde Egerer; Udo Bode; Carlo Schaller; Martina Deckert; Rolf Fimmers; Christoph Helmstaedter; Aslihan Atasoy; Thomas Klockgether; Uwe Schlegel
Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4489-95.
2003: John Strehl; Ulrich Mey; Axel Glasmacher; Benjamin Djulbegovic; Christine Mayr; Marcus Gorschlüter; Carsten Ziske; Ingo G H Schmidt-Wolf
High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis.
Haematologica 2003;88(11):1304-15.
2003: Carsten Ziske; C Schlie; Marcus Gorschlüter; Axel Glasmacher; Ulrich Mey; John Strehl; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine.
British journal of cancer 2003;89(8):1413-7.
2003: Hartmut Goldschmidt; Pieter Sonneveld; Friedrich W Cremer; Bronno van der Holt; Petra H M Westveer; Iris Breitkreutz; Axel Benner; Axel Glasmacher; Ingo G H Schmidt-Wolf; H Martin; D Hoelzer; Anthony Ho; Henk M Lokhorst
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients.
Annals of hematology 2003;82(10):654-9.
2003: Steffen Engelhart; J Hanfland; Axel Glasmacher; Ludmila Krizek; Ingo G H Schmidt-Wolf; Martin Exner
Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions.
The Journal of hospital infection 2003;54(4):300-4.
2003: Holger Palmedo; Agnieszka Manka-Waluch; Peter Albers; Ingo G H Schmidt-Wolf; Michael Reinhardt; Samer Ezziddin; Alexius Y Joe; Roland Roedel; Rolf Fimmers; Furn F Knapp; Stefan Guhlke; Hans-Jürgen Biersack
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2869-75.
2003: Ingo G H Schmidt-Wolf; Jürgen K Rockstroh; Uwe Schlegel; Hendrik Pels; Ulrich Mey; John Strehl; Rudolf Weiss; Dieter Huhn
Treatment options of AIDS-related lymphoma.
Expert opinion on pharmacotherapy 2003;4(8):1331-43.
2003: Marcus Gorschlüter; Corinna Hahn; A Fixson; Ulrich Mey; Carsten Ziske; Ernst Molitor; Regine Horré; Tilman Sauerbruch; Günter Marklein; Ingo G H Schmidt-Wolf; Axel Glasmacher
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(6):362-70.
2003: Gabriele D Schmidt-Wolf; Ingo G H Schmidt-Wolf
Gene therapy for hematological malignancies.
Clinical and experimental medicine 2003;3(1):4-14.
2003: Hinrich Abken; Andreas Hombach; Günter Reinhard; Angela Märten; Claudia Schlimper; Axel Glasmacher; Thomas Bieber; Ingo G H Schmidt-Wolf
Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences.
Leukemia & lymphoma 2003;44(4):583-92.
2003: Angela Märten; Sabine Renoth; Thomas Heinicke; Peter Albers; Andreas Pauli; Ulrich Mey; Reiner Caspari; Dimitri Flieger; Peter Hanfland; Alexander von Ruecker; Anna Maria Eis-Hübinger; Stefan Müller; Ingo Schwaner; Uwe Lohmann; Guido Heylmann; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
Human gene therapy 2003;14(5):483-94.
2003: Ulrich Mey; Marcus Gorschlüter; Carsten Ziske; Rolf Kleinschmidt; Axel Glasmacher; Ingo G H Schmidt-Wolf
Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial.
Anti-cancer drugs 2003;14(3):233-8.
2003: Ulrich Mey; Axel Glasmacher; Corinna Hahn; Marcus Gorschlüter; Carsten Ziske; M Mergelsberg; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(3):148-55.
2003: Gabriele D Schmidt-Wolf; Ingo G H Schmidt-Wolf
Non-viral and hybrid vectors in human gene therapy: an update.
Trends in molecular medicine 2003;9(2):67-72.
2003: Ingo G H Schmidt-Wolf; J K Rockstroh; H Schüller; A Hirner; Christian Grohe; H K Müller-Hermelink; Dieter Huhn
Malignant thymoma: current status of classification and multimodality treatment.
Annals of hematology 2003;82(2):69-76.
2003: Carsten Ziske; Jörg Mezger; Carlos Jiménez; Rolf Kleinschmidt; Hendrik Pels; Uwe Schlegel; Ingo G H Schmidt-Wolf
High-dose chemotherapy with autologous peripheral blood stem cell support for recurrent primary AFP-producing intracranial germinoma.
German medical science : GMS e-journal 2003;1():Doc03.
2003: Catharina Gross; Ingo G H Schmidt-Wolf; Srinivas Nagaraj; Robert Gastpar; Joachim W Ellwart; Leoni A Kunz-Schughart; Gabriele Multhoff
Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.
Cell stress & chaperones 2003;8(4):348-60.
2002: Angela Märten; Dimitri Flieger; Sabine Renoth; Silvia Weineck; Peter Albers; Markus Compes; Björn Schöttker; Carsten Ziske; Steffen Engelhart; Peter Hanfland; Ludmila Krizek; Cora Faber; Alexander von Ruecker; Stefan Müller; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.
Cancer immunology, immunotherapy : CII 2002;51(11-12):637-44.
2002: Carsten Ziske; Marcus Gorschlüter; Ulrich Mey; Ruth Offergeld; Axel Glasmacher; Ingo G H Schmidt-Wolf
Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer.
Anticancer research 2002;22(6B):3723-6.
2002: Angela Märten; Sabine Renoth; Ingo G H Schmidt-Wolf
Increase of the stimulatory effect of dendritic cells by pulsing with apoptotic bodies transfected with the MHC class II gene.
Molecular immunology 2002;39(7-8):395-8.
2002: Ingo G H Schmidt-Wolf; Jürgen K Rockstroh; Uwe Schlegel; Hendrik Pels; R Weiss; Dieter Huhn
New aspects in the treatment of AIDS-related lymphoma.
European journal of medical research 2002;7(7):295-303.
2002: Peter Buttgereit; Ingo G H Schmidt-Wolf
Gene therapy of lymphoma.
Journal of hematotherapy & stem cell research 2002;11(3):457-67.
2002: Günter Reinhard; Angela Märten; S M Kiske; F Feil; T Bieber; Ingo G H Schmidt-Wolf
Generation of dendritic cell-based vaccines for cancer therapy.
British journal of cancer 2002;86(10):1529-33.
2002: Marcus Gorschlüter; Günter Marklein; Katja Höfling; Ricarda Clarenbach; Stefanie Baumgartner; Corinna Hahn; Carsten Ziske; Ulrich Mey; Ricarda Heller; Anna Maria Eis-Hübinger; Tilman Sauerbruch; Ingo G H Schmidt-Wolf; Axel Glasmacher
Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology.
British journal of haematology 2002;117(2):351-8.
2002: Carsten Ziske; Björn Schöttker; Marcus Gorschlüter; Ulrich Mey; Rolf Kleinschmidt; Uwe Schlegel; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Acute transient encephalopathy after paclitaxel infusion: report of three cases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):629-31.
2002: G D Schmidt-Wolf; Ingo G H Schmidt-Wolf
Immunomodulatory gene therapy for haematological malignancies.
British journal of haematology 2002;117(1):23-32.
2002: Marcus Gorschlüter; Corinna Hahn; Carsten Ziske; Ulrich Mey; Björn Schöttker; Ernst Molitor; S Becker; Günter Marklein; Tilman Sauerbruch; Ingo G H Schmidt-Wolf; Axel Glasmacher
Low frequency of enteric infections by Salmonella, Shigella, Yersinia and Campylobacter in patients with acute leukemia.
Infection 2002;30(1):22-5.
2001: Angela Märten; Carsten Ziske; Björn Schöttker; Sabine Renoth; Silvia Weineck; Peter Buttgereit; Frank Schakowski; Alexander von Rücker; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2001;24(6):502-10.
2001: Marie von Lilienfeld-Toal; O Ebert; Ingo Theuerkauf; Axel Glasmacher; Ingo G H Schmidt-Wolf
Small bowel obstruction in acute myelogenous leukemia: stenosis or paralysis?
Annals of hematology 2001;80(10):611-3.
2001: Angela Märten; Sabine Renoth; Marie von Lilienfeld-Toal; Peter Buttgereit; Frank Schakowski; Axel Glasmacher; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells.
Haematologica 2001;86(10):1029-37.
2001: Marcus Gorschlüter; Axel Glasmacher; Corinna Hahn; Frank Schakowski; Carsten Ziske; Ernst Molitor; Günter Marklein; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Clostridium difficile infection in patients with neutropenia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(6):786-91.
2001: Peter Buttgereit; Frank Schakowski; Angela Märten; K Brand; Sabine Renoth; Carsten Ziske; Björn Schöttker; O Ebert; R Schroers; Ingo G H Schmidt-Wolf
Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
Cancer gene therapy 2001;8(6):430-9.
2001: Frank Schakowski; Marcus Gorschlüter; Claas Junghans; Matthias Schroff; Peter Buttgereit; Carsten Ziske; Björn Schöttker; Sven A König-Merediz; Tilman Sauerbruch; Burghardt Wittig; Ingo G H Schmidt-Wolf
A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(5 Pt 1):793-800.
2001: Angela Märten; Carsten Ziske; Björn Schöttker; Silvia Weineck; Sabine Renoth; Peter Buttgereit; Frank Schakowski; S König; Alexander von Rücker; A Allera; R Schroers; Tilman Sauerbruch; Burghardt Wittig; Ingo G H Schmidt-Wolf
Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs.
Cancer gene therapy 2001;8(3):211-9.
2001: Burghardt Wittig; Angela Märten; Tomislav Dorbic; Silvia Weineck; H Min; S Niemitz; B Trojaneck; Dimitri Flieger; S Kruopis; A Albers; Jürgen Löffel; Andreas Neubauer; Peter Albers; Stefan Müller; Tilman Sauerbruch; T Bieber; Dieter Huhn; Ingo G H Schmidt-Wolf
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.
Human gene therapy 2001;12(3):267-78.
2001: Agnieszka Korfel; J Finke; Ingo G H Schmidt-Wolf; Eckhard Thiel
5. Report on workshop: Primary CNS lymphoma.
Annals of hematology 2001;80 Suppl 3():B20-3.
2001: Marcus Gorschlüter; Axel Glasmacher; Corinna Hahn; Claudia C Leutner; Günter Marklein; J Remig; Ingo G H Schmidt-Wolf; Tilman Sauerbruch
Severe abdominal infections in neutropenic patients.
Cancer investigation 2001;19(7):669-77.
2001: Carsten Ziske; M Meybehm; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Littoral cell angioma as a rare cause of splenomegaly.
Annals of hematology 2001;80(1):45-8.
2001: Dimitri Flieger; A S Hoff; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression.
Clinical and experimental immunology 2001;123(1):9-14.
2001: Carsten Ziske; Angela Märten; Björn Schöttker; Peter Buttgereit; Frank Schakowski; Marcus Gorschlüter; Alexander von Rücker; christian scheffold; N Chao; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(1):54-60.
2000: Gerd Röpke; O Ebert; Angela Märten; P Lefterova; B Micka; Peter Buttgereit; S Niemitz; B Trojaneck; GD Schmidt-Wolf; A V Rücker; Dieter Huhn; Burghardt Wittig; Ingo G H Schmidt-Wolf
Increase in proliferation rate and normalization of TNF-alpha secretion by blockage of gene transfer-induced apoptosis in lymphocytes using low-dose cyclosporine A.
Cancer gene therapy 2000;7(11):1411-3.
2000: Dimitri Flieger; P Kufer; I Beier; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon alpha and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cells.
Cancer immunology, immunotherapy : CII 2000;49(8):441-8.
2000: P Lefterova; Frank Schakowski; Peter Buttgereit; christian scheffold; Dieter Huhn; Ingo G H Schmidt-Wolf
Expansion of CD3+CD56+ cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy.
Haematologica 2000;85(10):1108-9.
2000: B Zoll; P Lefterova; O Ebert; Dieter Huhn; A Von Ruecker; Ingo G H Schmidt-Wolf
Modulation of cell surface markers on NK-like T lymphocytes by using IL-2, IL-7 or IL-12 in vitro stimulation.
Cytokine 2000;12(9):1385-90.
2000: Dimitri Flieger; Ulrich Spengler; I Beier; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
Zeitschrift für Gastroenterologie 2000;38(8):615-22.
2000: Angela Märten; Carsten Ziske; Björn Schöttker; Sabine Renoth; Silvia Weineck; Peter Buttgereit; Frank Schakowski; D Klingmüller; christian scheffold; Alexander von Rücker; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients.
International journal of colorectal disease 2000;15(4):197-205.
2000: Peter Buttgereit; Silvia Weineck; Gerd Röpke; Angela Märten; K Brand; Thomas Heinicke; Wolfgang H Caselmann; Dieter Huhn; Ingo G H Schmidt-Wolf
Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.
Cancer gene therapy 2000;7(8):1145-55.
2000: Dimitri Flieger; Ulrich Spengler; I Beier; Rolf Kleinschmidt; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(4):480-6.
2000: Angela Märten; Björn Schöttker; Carsten Ziske; Silvia Weineck; Peter Buttgereit; Dieter Huhn; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 protein.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(4):464-72.
2000: Alexander von Ruecker; Ingo G H Schmidt-Wolf
Strategies to evaluate metabolic stress and catabolism by means of immunological variables.
Clinical nutrition (Edinburgh, Scotland) 2000;19(3):147-56.
2000: B Micka; B Trojaneck; S Niemitz; P Lefterova; S Kruopis; Dieter Huhn; Burghardt Wittig; D Schadendorf; Ingo G H Schmidt-Wolf
Comparison of non-viral transfection methods in melanoma cell primary cultures.
Cytokine 2000;12(6):828-33.
2000: P Lefterova; Angela Märten; Peter Buttgereit; Silvia Weineck; christian scheffold; Dieter Huhn; Ingo G H Schmidt-Wolf
Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(3):304-10.
2000: B Trojaneck; S Niemitz; B Micka; P Lefterova; R Blasczyk; christian scheffold; Dieter Huhn; Ingo G H Schmidt-Wolf
Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures.
Cancer biotherapy & radiopharmaceuticals 2000;15(2):169-74.
2000: Christof Lamberti; Matthias Jungck; Reiner Caspari; Ingo G H Schmidt-Wolf; Tilman Sauerbruch
[Therapy and after-care of familial adenomatous polyposis and hereditary colorectal carcinoma without polyposis].
Deutsche medizinische Wochenschrift (1946) 2000;125(7):189-91.
2000: Reiner Caspari; Matthias Jungck; Christof Lamberti; Ingo G H Schmidt-Wolf; Waltraut Friedl; Peter Propping
[The diagnosis of hereditary colorectal carcinomas].
Deutsche medizinische Wochenschrift (1946) 2000;125(6):153-8.
2000: christian scheffold; Björn Schöttker; P Lefterova; M Csipai; Axel Glasmacher; Dieter Huhn; Andreas Neubauer; Ingo G H Schmidt-Wolf
Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agent.
Acta haematologica 2000;104(2-3):72-9.
2000: P Lefterova; Angela Märten; Peter Buttgereit; Frank Schakowski; B Micka; christian scheffold; Ingo G H Schmidt-Wolf
Induction of apoptosis in B lymphoma cells by activation with CD40L.
Acta haematologica 2000;103(3):168-71.
1999: Ingo G H Schmidt-Wolf; S Finke; B Trojaneck; A Denkena; P Lefterova; Nimrod Schwella; Hans-Gert Heuft; G Prange; M Korte; M Takeya; Tomislav Dorbic; Andreas Neubauer; Burghardt Wittig; Dieter Huhn
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.
British journal of cancer 1999;81(6):1009-16.
1999: O Ebert; Gerd Röpke; Angela Märten; P Lefterova; B Micka; Peter Buttgereit; S Niemitz; B Trojaneck; GD Schmidt-Wolf; Dieter Huhn; Burghardt Wittig; Ingo G H Schmidt-Wolf
TNF-alpha secretion and apoptosis of lymphocytes mediated by gene transfer.
Cytokines, cellular & molecular therapy 1999;5(3):165-73.
1999: Benno Mann; Alexei Gratchev; CM Böhm; Marie-Luise Hanski; Hans-Dieter Foss; G Demel; B Trojanek; Ingo G H Schmidt-Wolf; Harald Stein; Ernst-Otto Riecken; Heinz J Buhr; Christoph Hanski
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas.
British journal of cancer 1999;79(7-8):1262-9.
1999: Axel Glasmacher; Corinna Hahn; Ernst Molitor; Günter Marklein; Tilman Sauerbruch; Ingo G H Schmidt-Wolf
Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules.
Mycoses 1999;42(11-12):591-600.
1999: Axel Glasmacher; Corinna Hahn; Claudia C Leutner; Ernst Molitor; Eva Wardelmann; C Losem; Tilman Sauerbruch; Günter Marklein; Ingo G H Schmidt-Wolf
Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.
Mycoses 1999;42(7-8):443-51.
1999: Axel Glasmacher; Corinna Hahn; Ernst Molitor; Tilman Sauerbruch; Ingo G H Schmidt-Wolf; Günter Marklein
Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Mycoses 1999;42(5-6):395-402.
1998: B Zoll; P Lefterova; M Csipai; S Finke; B Trojaneck; O Ebert; B Micka; K Roigk; M Fehlinger; GD Schmidt-Wolf; Dieter Huhn; Ingo G H Schmidt-Wolf
Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12.
Cancer immunology, immunotherapy : CII 1998;47(4):221-6.
1998: M Müller; christian scheffold; P Lefterova; Dieter Huhn; Andreas Neubauer; Ingo G H Schmidt-Wolf
Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemia.
Leukemia & lymphoma 1998;31(3-4):335-41.
1998: Axel Glasmacher; Ernst Molitor; Corinna Hahn; K Bomba; Santiago Ewig; Claudia C Leutner; Eva Wardelmann; Ingo G H Schmidt-Wolf; Jörg Mezger; Günter Marklein; Tilman Sauerbruch
Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Leukemia 1998;12(9):1338-43.
1998: S Finke; B Trojaneck; P Lefterova; M Csipai; Ernst Wagner; R Kircheis; Andreas Neubauer; Dieter Huhn; Burghardt Wittig; Ingo G H Schmidt-Wolf
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene.
Gene therapy 1998;5(1):31-9.
1997: S Finke; B Trojaneck; Peter Möller; Dirk Schadendorf; Andreas Neubauer; Dieter Huhn; Ingo G H Schmidt-Wolf
Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene to autologous and allogeneic immunologic effector cells.
Cancer gene therapy 1997;4(4):260-8.
1997: P Lefterova; Ingo G H Schmidt-Wolf
Coexpression of lymphoid and myeloid markers on cell surfaces.
Leukemia & lymphoma 1997;26(1-2):27-33.
1997: O Ebert; S Finke; A Salahi; M Herrmann; B Trojaneck; P Lefterova; Ernst Wagner; R Kircheis; Dieter Huhn; Folke Schriever; Ingo G H Schmidt-Wolf
Lymphocyte apoptosis: induction by gene transfer techniques.
Gene therapy 1997;4(4):296-302.
1997: GD Schmidt-Wolf; R S Negrin; Ingo G H Schmidt-Wolf
Activated T cells and cytokine-induced CD3+CD56+ killer cells.
Annals of hematology 1997;74(2):51-6.
1997: Folke Schriever; D Korinth; A Salahi; P Lefterova; Ingo G H Schmidt-Wolf; S I Behr
Human T lymphocytes bind to germinal centers of human tonsils via integrin alpha4/VCAM-1 and LFA-1/ICAM-1 and -2.
European journal of immunology 1997;27(1):35-9.
1996: GD Schmidt-Wolf; Ingo G H Schmidt-Wolf
Cancer and gene therapy.
Annals of hematology 1996;73(5):207-18.
1996: Ingo G H Schmidt-Wolf; P Lefterova; V Johnston; christian scheffold; M Csipai; B A Mehta; T Tsuruo; Dieter Huhn; Robert S Negrin
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells.
Cellular immunology 1996;169(1):85-90.
1995: GD Schmidt-Wolf; Ingo G H Schmidt-Wolf
Bone marrow and clinical gene therapy.
Journal of hematotherapy 1995;4(6):551-61.
1995: B A Mehta; Ingo G H Schmidt-Wolf; Irving L Weissman; Robert S Negrin
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells.
Blood 1995;86(9):3493-9.
1995: Ingo G H Schmidt-Wolf; B Grimm; P Lefterova; V Johnston; christian scheffold; Dieter Huhn; Stefan Serke
Propagation of large numbers of cells of a human mixed-lineage T-lymphoid/myeloid.
British journal of haematology 1995;90(3):512-7.
1995: GD Schmidt-Wolf; Ingo G H Schmidt-Wolf
Cytokines and clinical gene therapy.
European journal of immunology 1995;25(4):1137-40.
1995: GD Schmidt-Wolf; Ingo G H Schmidt-Wolf
Cytokines and gene therapy.
Immunology today 1995;16(4):173-5.
1995: christian scheffold; K Brandt; V Johnston; P Lefterova; B Degen; M Schöntube; Dieter Huhn; Andreas Neubauer; Ingo G H Schmidt-Wolf
Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia.
Bone marrow transplantation 1995;15(1):33-9.
1994: GD Schmidt-Wolf; Ingo G H Schmidt-Wolf
Human cancer and gene therapy.
Annals of hematology 1994;69(6):273-9.
1994: Ingo G H Schmidt-Wolf; D Huhn; A Neubauer; Burghardt Wittig
Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal cell carcinoma, melanoma, or with lymphoma.
Human gene therapy 1994;5(9):1161-8.
1994: Ingo G H Schmidt-Wolf; P Lefterova; V Johnston; Dieter Huhn; Karl G Blume; Robert S Negrin
Propagation of large numbers of T cells with natural killer cell markers.
British journal of haematology 1994;87(3):453-8.
1994: Nimrod Schwella; R Schwerdtfeger; V König; R Blasczyk; H Schmid; Ingo G H Schmidt-Wolf; Günter Henze; Wolfgang Siegert
Allogeneic bone marrow transplantation for recurrence of leukemia after autologous bone marrow transplantation.
Transplantation 1994;57(8):1263-5.
1994: Nimrod Schwella; V König; R Schwerdtfeger; Ingo G H Schmidt-Wolf; H Schmid; Hanno Riess; Wolfgang Siegert
Ondansetron for efficient emesis control during total body irradiation.
Bone marrow transplantation 1994;13(2):169-71.
1993: Ingo G H Schmidt-Wolf; P Lefterova; B A Mehta; L P Fernandez; Dieter Huhn; Karl G Blume; Irving L Weissman; Robert S Negrin
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.
Experimental hematology 1993;21(13):1673-9.
1993: Ingo G H Schmidt-Wolf; O Liang; Sussan Dejbakhsh-Jones; H Wang; L Cheng; Bari Holm Nazario; R Bell; Samuel Strober
Homogeneous antigen receptor beta-chain genes in cloned CD4- CD8- alpha beta T suppressor cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(10):5348-53.
1993: P Lefterova; Robert S Negrin; Andreas Neubauer; Dieter Huhn; Karl G Blume; Ingo G H Schmidt-Wolf
Efficient generation and characterization of tumor cell subclones with different adhesion pathways involved in cell lysis.
Haematologica 1993;78(6):353-8.
1993: Ingo G H Schmidt-Wolf; R Schwerdtfeger; Nimrod Schwella; J Gallardo; H J Schmid; Dieter Huhn; Wolfgang Siegert
Diffuse pulmonary alveolar hemorrhage after allogeneic bone marrow transplantation.
Annals of hematology 1993;67(3):139-41.
1993: Nimrod Schwella; R Schwerdtfeger; Ingo G H Schmidt-Wolf; H Schmid; Wolfgang Siegert
Pneumococcal arthritis after allogeneic bone marrow transplantation.
Bone marrow transplantation 1993;12(2):165-6.
1992: Ingo G H Schmidt-Wolf; Sussan Dejbakhsh-Jones; N Ginzton; P Greenberg; Samuel Strober
T-cell subsets and suppressor cells in human bone marrow.
Blood 1992;80(12):3242-50.
1992: Ingo G H Schmidt-Wolf; M Aihara; Robert S Negrin; Karl G Blume; Nelson J Chao
In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservation.
Transfusion 1992;32(1):42-5.
1991: Ingo G H Schmidt-Wolf; Robert S Negrin; H P Kiem; Karl G Blume; Irving L Weissman
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
The Journal of experimental medicine 1991;174(1):139-49.
1991: M Aihara; Y Aihara; G Schmidt-Wolf; Ingo G H Schmidt-Wolf; Branimir I Sikic; Karl G Blume; Nelson J Chao
A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy.
Blood 1991;77(9):2079-84.
1991: Robert S Negrin; H P Kiem; Ingo G H Schmidt-Wolf; K G Blume; M L Cleary
Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging.
Blood 1991;77(3):654-60.
1989: Ingo G H Schmidt-Wolf; M Aihara; Robert S Negrin; Karl G Blume; Nelson J Chao
Lymphokine-activated killer cell activity after cryopreservation.
Journal of immunological methods 1989;125(1-2):185-9.